Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov;85(5):573-607.
doi: 10.1016/j.jinf.2022.08.005. Epub 2022 Aug 9.

Is SARS-CoV-2 an oncogenic virus?

Alberto Gómez-Carballa  1 , Federico Martinón-Torres  2 , Antonio Salas  3
Affiliations
Comment

Is SARS-CoV-2 an oncogenic virus?

Alberto Gómez-Carballa et al. J Infect. 2022 Nov.
No abstract available

Keywords: COVID-19; Cancer; SARS-CoV-2; TP53.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors report no conflict of interest.

Figures

Fig. 1
Fig. 1
(A) TP53 gene expression in blood samples from COVID-19 patients and healthy controls from the RNAseq dataset (7) and stratified by WHO severity score (left). Correlation between days of symptoms to sample collection and TP53 expression in the RNAseq dataset (right). (B) TP53 gene expression in blood samples from COVID-19 patients and healthy controls from the n-Counter dataset (8) and stratified by WHO severity score (left); patients from this cohort partially overlap with those in the RNAseq dataset. Correlation between days of symptoms to sample collection and TP53 expression in the n-Counter dataset (right). Asymptomatic patients were not included in the correlation analyses (r = spearman correlation coefficient). (C) TP53 gene expression in blood samples from mild/moderate (left) and severe/critical (right) long-COVID-19 patients as well as healthy controls from Ryan et al. (9) collected at different timepoints post infection (w.p.i = weeks post infection); here we used the authors’ scores of severity (9).
See this image and copyright information in PMC

Comment on

References

    1. Wu X., Peng H., Xiong S., Li C., Zhong R., He J., et al. Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer. J Infect. 2022;85(1):e1–e3. PubMed PMID: 35561867. Pubmed Central PMCID: PMC9088088. Epub 20220510. - PMC - PubMed
    1. Gao R., Xu Y., Zhu G., Zhou S., Li H., Han G., et al. Genetic variation associated with COVID-19 is also associated with endometrial cancer. J Infect. 2022;84(5):e85–ee6. PubMed PMID: 35077768. Pubmed Central PMCID: PMC8801793. Epub 20220122. - PMC - PubMed
    1. Stingi A., Cirillo L. SARS-CoV-2 infection and cancer: evidence for and against a role of SARS-CoV-2 in cancer onset. Bioessays. 2021;43(8) PubMed PMID: 34081334. Pubmed Central PMCID: PMC8209829. Epub 20210603. - PMC - PubMed
    1. Cardozo C.M., Hainaut P. Viral strategies for circumventing p53: the case of severe acute respiratory syndrome coronavirus. Curr Opin Oncol. 2021;33(2):149–158. PubMed PMID: 33405482. Pubmed Central PMCID: PMC7924916. - PMC - PubMed
    1. Ma-Lauer Y., Carbajo-Lozoya J., Hein M.Y., Muller M.A., Deng W., Lei J., et al. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci U S A. 2016;113(35):E5192–E5201. PubMed PMID: 27519799. Pubmed Central PMCID: PMC5024628. Epub 20160812. - PMC - PubMed